España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Legend Biotech
LEGN
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$46.30
0.39
0.85%
At Close: -
$46.30
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Watch
Legend Biotech (LEGN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Legend Biotech (NASDAQ:LEGN) Stock
Legend Biotech Stock (NASDAQ: LEGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 03, 2024
BMO Capital Maintains Outperform on Legend Bi...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Tuesday, July 02, 2024
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
Vandana Singh
Legend Biotech Reports Overall Survival Resul...
Benzinga Newsdesk
Friday, June 21, 2024
Assessing Legend Biotech: Insights From 15 Financial Analysts
Benzinga Insights
RBC Capital Reiterates Outperform on Legend B...
Benzinga Newsdesk
Monday, June 17, 2024
Piper Sandler Reiterates Overweight on Legend...
Benzinga Newsdesk
Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst
Priya Nigam
Truist Securities Initiates Coverage On Legen...
Benzinga Newsdesk
Sunday, June 09, 2024
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Lekha Gupta
Thursday, June 06, 2024
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Tuesday, June 04, 2024
Unveiling 18 Analyst Insights On Legend Biotech
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Monday, June 03, 2024
Johnson & Johnson Announces Results From A Su...
Benzinga Newsdesk
Friday, May 24, 2024
HC Wainwright & Co. Maintains Buy on Legend B...
Benzinga Newsdesk
Thursday, May 23, 2024
Deutsche Bank Initiates Coverage On Legend Bi...
Benzinga Newsdesk
Wednesday, May 22, 2024
MaxCyte Signs License Agreement With Legend B...
Benzinga Newsdesk
Tuesday, May 14, 2024
RBC Capital Maintains Outperform on Legend Bi...
Benzinga Newsdesk
Legend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Legend B...
Benzinga Newsdesk
Monday, May 13, 2024
Legend Biotech Expects Cash And Equivalents O...
Benzinga Newsdesk
Legend Biotech Q1 2024 GAAP EPS $(0.16) Beats...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Tuesday, April 23, 2024
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Monday, April 22, 2024
Legend Biotech Announces Carvykti Approved By...
Benzinga Newsdesk
Friday, April 19, 2024
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Vandana Singh
Wednesday, April 17, 2024
Analyst Ratings For Legend Biotech
Benzinga Insights
Scotiabank Upgrades Legend Biotech to Sector ...
Benzinga Newsdesk
Tuesday, April 16, 2024
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Legend Biotech Earlier Announced CARVYKTI Gen...
Benzinga Newsdesk
Monday, April 08, 2024
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
Vandana Singh
On Friday April 5, 2024, Legend Biotech Repor...
Benzinga Newsdesk
Wednesday, April 03, 2024
Cantor Fitzgerald Initiates Coverage On Legen...
Benzinga Newsdesk
Monday, April 01, 2024
Unveiling 9 Analyst Insights On Legend Biotech
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Wednesday, March 20, 2024
Legend Biotech shares are trading lower after...
Benzinga Newsdesk
GenScript Losses Shrink On Strong Growth For Cancer Cell Therapy
The Bamboo Works
Tuesday, March 19, 2024
Legend Biotech shares are trading lower after...
Benzinga Newsdesk
Legend Biotech Filed For Mixed Shelf Offering...
Charles Gross
Monday, March 18, 2024
UBS Maintains Buy on Legend Biotech, Raises P...
Benzinga Newsdesk
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Friday, March 15, 2024
Legend Biotech Announces FDA Oncologic Drugs ...
Benzinga Newsdesk
Wednesday, March 13, 2024
FDA To Review Two Cell Therapies For Multiple Myeloma This Week - Johnson & Johnson And Bristol-Myers
Vandana Singh
Legend Biotech shares are trading higher afte...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Legend ...
Benzinga Newsdesk
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Avi Kapoor
Raymond James Initiates Coverage On Legend Bi...
Benzinga Newsdesk
Tuesday, March 12, 2024
RBC Capital Reiterates Outperform on Legend B...
Benzinga Newsdesk
Monday, March 11, 2024
Legend Biotech shares are trading higher afte...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch